Medications

First biosimilar approved to treat multiple sclerosis

The U.S. Food and Drug Administration approved Tyruko (natalizumab-sztn), the first biosimilar to Tysabri (natalizumab) injection, for the treatment of relapsing forms of multiple sclerosis, the agency announced Thursday.

Medications

The drugs don't work

(Medical Xpress)—Drugs that do not represent value for money or are medically unproven may be increasingly reaching one of Europe's largest pharmaceutical markets, according to research undertaken by Cambridge sociologist ...

Diseases, Conditions, Syndromes

FDA gives nod to botox to treat overactive bladder

(HealthDay)—The U.S. Food and Drug Administration on Friday gave its approval for the use of Botox against a form of urinary incontinence known as overactive bladder.

Medications

Antidote for cocaine overdose shows promise in lab tests

Scientists at The Scripps Research Institute have shown that an injectable solution can protect mice from an otherwise lethal overdose of cocaine. The findings could lead to human clinical trials of a treatment designed to ...

Medications

Biostatistician helps FDA approve first biosimilar drug

Bernard "Chip" Cole got the call in late December. The U.S. Food and Drug Administration summoned the University of Vermont biostatistician for another mission. Since 2013, Cole has sat on an important FDA panel that assesses ...

Medications

FDA: Akynzeo approved for chemo-related nausea / vomiting

(HealthDay)—The combination drug Akynzeo (netupitant and palonosetron) has been approved by the U.S. Food and Drug Administration to treat nausea and vomiting among people undergoing chemotherapy, the agency said Friday ...

page 2 from 6